About ITM
ITM is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer...
CatalYm GmbH is a clinical-stage biotechnology company dedicated to advancing cancer treatment through pioneering Visugromab, a recombinant antibody targeting the immunosuppressive cytokine GDF-15. Under physiological conditions, GDF-15 is essential...
About ITM
ITM is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer ...
Research assistant position (m/f/d) in the context of a third-party-funded project for development of a module for mobile radiation detection on patients.
Institution
The Bundeswehr guarantees the security, sovereignty, and foreign policy capab...
About ITM
ITM is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer ...
Über uns
Wir machen Nachhaltigkeit profitabel. Und Profitabilität nachhaltig. Das ist unsere Antwort auf eine sich rasant verändernde Welt. Wir sind einer der großen Asset Manager in Deutschland - seit nunmehr 35 Jahren. Nachhaltigkeit und Zukunf...
Über ITM
Bei ITM Isotope Technologies Munich SE entwickeln, produzieren und vertreiben wir zielgerichtete diagnostische und therapeutische Radiopharmazeutika sowie Radioisotope für die Krebsbehandlung auf globaler Ebene. Unsere Mission bei ITM be...
Über ITM
Bei ITM Isotope Technologies Munich SE entwickeln, produzieren und vertreiben wir zielgerichtete diagnostische und therapeutische Radiopharmazeutika sowie Radioisotope für die Krebsbehandlung auf globaler Ebene. Unsere Mission bei ITM be...
Research assistant position (m/f/d) in the context of a third-party-funded project for radiation induced gene expression measurements in saliva and blood
Institution
The Bundeswehr guarantees the security, sovereignty, and foreign policy capabi...
CatalYm GmbH is a clinical-stage biotechnology company dedicated to advancing cancer treatment through pioneering Visugromab, a recombinant antibody targeting the immunosuppressive cytokine GDF-15. Under physiological conditions, GDF-15 is essential...
